TE_16
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | L1MC1_3end |
---|---|
TE superfamily | L1 |
TE class | LINE |
Gene | C1orf159 |
Class | Chimeric |
Coding | Non-coding, Other |
Tumor-specific score | 1.18 |
Counts of samples | TCGA_tumor:110; TCGA_normal:4; GTEx:101 |
TSS | chr1(-):1100489 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_16.21 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1084066,1084086,1084353,1084383,1084481,1084506,1085878,1086012,1087139,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092293,1100452,1100490 |
teRNA_16.22 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1087184,1087204,1087502,1087597,1090353,1090428,1091472,1091565,1091991,1092293,1100452,1100490 |
teRNA_16.23 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1087184,1087204,1087502,1087597,1090353,1090587,1091472,1091565,1091991,1092293,1100452,1100490 |
teRNA_16.24 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1087184,1087204,1087502,1087597,1090353,1090428,1091472,1091609,1091991,1092293,1100452,1100490 |
teRNA_16.25 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1087577,1087597,1090353,1090428,1091472,1091565,1091991,1092293,1100452,1100490 |
teRNA_16.26 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1090408,1090428,1091278,1091374,1091472,1091565,1091991,1092293,1100452,1100490 |
teRNA_16.27 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1091545,1091565,1091991,1092293,1100452,1100490 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.